<img src="https://publish-01.obsidian.md/access/744ac39d33cabbc297b91373bfcac24d/bin/images/Colombia_map.png" alt="Colombia" class="page-header-sidebar-image"> Colombia has provisions in its legislation relating to the granting of compulsory licences. These can be found in Decree 1074 of 2015. Compulsory licenses in Colombia can be granted under several circumstances, including: - Public Interest or National Emergency: The government may declare certain situations as matters of public interest or national emergency, justifying the issuance of a compulsory license to ensure public access to essential products or technologies. - Anti-Competitive Practices: If a patent holder engages in anti-competitive practices, such as abuse of dominant position or restrictive trade practices, a compulsory license can be issued to rectify the situation. - Failure to Exploit the Patent: If the patent is not being exploited within the national territory, and the lack of exploitation affects public interest, a compulsory license may be granted to promote the utilization of the patented invention. More information can be found [here](https://www.wipo.int/wipolex/en/legislation/details/18421 ). ## Compulsory licences Colombia has been requested to issue a compulsory licence for [[Dolutegravir]] by the government. The compulsory licence has not been issued because of an unknown reason. Colombia has been requested to issue a compulsory licence for [[Imatinib]] by civil society. The compulsory licence has not been issued because the application is still pending. Colombia has been requested to issue a compulsory licence for [[Nirmatrelvir/ritonavir]] by civil society. The compulsory licence has not been issued because the application is still pending. Colombia has been requested to issue a compulsory licence for [[DAAs]] by civil society. The compulsory licence has not been issued because the application is still pending.